FILTER
FILTERED INTERVIEW RESULTS
Fatih Yedikardeş
GENERAL MANAGER, DAIICHI SANKYO
Daiichi is a global pharmaceutical company that is developing Turkey as a regional hub.
Bharat Desai
MANAGING DIRECTOR, BHARAT PARENTERALS LIMITED
Bharat Parenterals is a research driven pharmaceutical company with a dedicated facility for antiretroviral drugs as well as a facility for general and B-lactam group of drugs.
John Patrick Oroho
EXECUTIVE VICE PRESIDENT AND CHIEF STRATEGY OFFICER, PORZIO LIFE SCIENCES, LLC
Porzio Life Sciences, LLC (PorzioLS) is a provider of compliance operations products and services for the life sciences industry, and a wholly‐owned subsidiary of the Porzio, Bromberg & Newman, P.C. law firm.
Zafer Toksoz
CHAIRMAN, ARVEN PHARMACEUTICALS
Arven Pharmaceuticals is an R&D based high-tech pharmaceutical company with a focus on research and development, manufacturing and marketing of high-tech pharmaceutical products, including biotech drugs and multi-dose innovative devices for dry powder inhalers.
Enrique Häusermann
PRESIDENT, ASSOCIAZIONE NAZIONALE INDUSTRIE FARMACI GENERICI E BIOSIMILARI (ASSOGENERICI)
Assogenerici is the Italian association that represents the country’s generic and biosimilar pharmaceutical industry.
Süha Taşpolatoğlu
CEO, ABDI IBRAHIM
Abdi İbrahim was founded in 1912 and has been the leader of Turkey’s Pharmaceutical Industry for 17 years, and boasts the largest product portfolio in the sector, with more than 200 brands and over 450 products.
Hüseyin Yılmaz & Ece Öztürk
MANAGING DIRECTOR, GENERAL MANAGER & BUSINESS STRATEGY CONSULTANT, HASBIOTECH
Founded in 2009, Hasbiotech is driven to create and manufacture an original Turkish medicine starting from scratch and is establishing a manufacturing site for local production of biotechnological products.
Ahmet Altug Oguz
CEO, TÜM EKİP ILAÇ
Tüm Ekip Pharmaceuticals was established in 2000 and is a specialized injectable pharmaceutical producer, with capability to produce seven different sterile forms.
Arun D. Joshi
CHAIRMAN AND MANAGING DIRECTOR, SURYA LIFE SCIENCES
Established in the year 2002, Surya Life Sciences is a manufacturer, exporter, and supplier of a wide assortment of bulk drug intermediates and fine API chemicals.
Paolo Russolo
PRESIDENT, ASCHIMFARMA
Aschimfarma represents Italian producers of pharmaceutical ingredients and helps advise them on regulations across the world.
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENT PUBLICATIONS
Peru Mining 2024 Pre-Release II
As the second half of 2024 approaches, Peru stands at a crossroads. According to the latest figures, the Democratic Republic of Congo has surpassed Peru as the second-largest copper producer. Cabinet changes under Boluarte's administration and ongoing corruption cases have taken a toll on investor confidence, and illegal mining remains a pressing issue. However, not everything is lost for the Andean country, and the mining sector presents growth opportunities.
As the second half of 2024 approaches, Peru stands at a crossroads. According to the latest figures, the Democratic Republic of Congo has surpassed Peru as the second-largest copper producer. Cabinet changes under Boluarte's administration and ongoing corruption cases have taken a toll on investor confidence, and illegal mining remains a pressing issue. However, not everything is lost for the Andean country, and the mining sector presents growth opportunities.
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
